Neuronal nicotinic acetylcholine receptor partial agonists as therapeutics for chronic tinnitus
AssigneeBoard of Trustees of Southern Illinois University
InventorsDonald Caspary, Thomas Brozoski, Brandon Cox
Life of this patent
Estimating the term…
Abstract
A method for treating a subject with symptoms of tinnitus and pharmaceutical compositions for treating tinnitus, the pharmaceutical compositions comprising one or more of the following: sazetidine, a pharmaceutically acceptable salt of sazetidine, varenicline, a pharmaceutically acceptable salt of varenicline, or any combination thereof.
Claims20
A method for treating a subject in need of treatment for tinnitus, the method comprising:
- administering to the subject a pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and a therapeutically effective amount of sazetidine, varenicline, a pharmaceutically acceptable salt of sazetidine, a pharmaceutically acceptable salt of varenicline, or any combination thereof.
A pharmaceutical composition for use in treating tinnitus, wherein the pharmaceutical composition comprises one or more pharmaceutically acceptable excipients and wherein the composition is characterized in that it comprises a therapeutically effective amount for treating tinnitus of an active compound wherein the active compound is one or more of the following:
- sazetidine, varenicline, a pharmaceutically acceptable salt of sazetidine, a pharmaceutically acceptable salt of varenicline, a sazetidine prodrug, a varenicline prodrug, a solvate of sazetidine, a solvate of varenicline, a hydrate of sazetidine, a hydrate of varenicline, or any combination thereof.
Dependencies are inferred from the claim text.